It's like "fake news", Daubers. There were more drugs in Cellceutix's pipeline than you may be aware of. Are you aware of the promising compound for autism that was shelved? Brilacidin for ABSSSI has been shelved now for what, 2 years? The company changed course on Brilacidin. Are you aware of the significant delays that Prurisol met with? Back in 2013 Prurisol was moving into a P2/3 lol. So no, only now concluding a P2b is not good progress. It should not take 5+ years to move K from IND to P2a. I'm on planet earth, Daubers. You may want to consider not just the quantity of compounds but where those compounds are in the trial phase and how long that has taken and with how much dilution.
Market Data 
Markets 
AI
